In bladder cancer, the knockdown of TNFRSF14 significantly enhanced the proliferation of bladder cancer cells through the activation of the Wnt/β-catenin-dependent pathway46. This evidence concerns the gene TNFRSF14 and urinary bladder carcinoma.